Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Adamis Pharmaceuticals Announces $11.1 Million Registered Direct Offering
-
Maxim Group Downgrades GrubHub Inc. (GRUB) to Hold
-
Jeff Kahn Appointed BroadSoft's Chief Transformation Officer
-
Onconova Announces Expiration of Oversubscribed Rights Offering
-
Onconova Adjusts Pricing of Rights Offering
-
Chipotle sales miss as food freebies fail to lure diners
-
OncoSec Medical (ONCS) PT Cut to $5 at Maxim Group, Keeps Buy
-
Streetinsider.com's Hot Lunchtime Reads 7/21: (PFE) (TSLA) (OPTT) (ADMP)
-
Adamis Pharmaceuticals (ADMP) PT Cut to $10 at Maxim Group as 'Buy' Maintained
-
Biostage (BSTG) PT Cut to $3 at Maxim Group
-
Maxim Group Reiterates Bullish View on Cytori Therapeutics (CYTX) Following Study Using ADRCs to Maxillofacial Bone Regeneration
-
PlacementTracker Publishes First Half 2016 PIPE Market League Tables
-
Brainstorm Cell (BCLI) ALS Trial Results 'Robust' - Maxim Group
-
Maxim Group Downgrades Syntel, Inc. (SYNT) to Hold
-
CytoSorbents (CTSO) Bullish View Reiterated at Maxim Group as Two Distributors Added
-
Maxim Group Downgrades The KEYW Holding Corporation (KEYW) to Hold
-
Mast Therapeutics (MSTX) Could Heat Up as Data Rolls in this Summer - Maxim Group
-
Prima BioMed (PBMD) Immunotherapy Delivery Method Looks Promising - Maxim Group
-
Sapience Therapeutics Completes $22.5 Million Series A Financing
-
Streetinsider.com's Hot Lunchtime Reads 7/11: (WMT) (MDCO) (MMS) (PSTI)
-
Maxim Group Remains Bullish on Celsion (CLSN) Following Announced Phase lll OPTIMA Study
-
Maxim Group Reiterates Buy on Pluristem Therapeutics (PSTI) Following Announced Contract with Global CRO
-
Maxim Group Cuts Price Target on Galena Biopharma (GALE) After Meeting with Management
-
Amedica Announces Closing of $12.7 Million Public Offering and Full Exercise of Over-Allotment Option
-
Keryx Biopharmaceuticals (KERX) PT Raised to $9 at Maxim Group
-
Onconova Announces Commencement of Subscription Period for Previously Announced Rights Offering
-
Juno Therapeutics (JUNO): Rocket Likely To Continue - Maxim
-
Maxim Group Starts TrovaGene (TROV) at Buy, $12 PT
-
Stellar Biotechnologies Announces Closing of Registered Direct Offering
-
Cytosorbents (CTSO): Secures $10M Non-Dilutive Financing - Maxim
-
Mesoblast (MESO): Was Teva Ever There? - Maxim Group
-
Amedica (AMDA) Prices Offering at $1 Per Unit
-
Amedica Announces Pricing of $11 Million Public Offering
-
Onconova Reminds Shareholders That Rights Offering Ownership Day is Friday, July 1, 2016
-
Stellar Biotechnologies (SBOT) Prices $6.75M Registered Direct Offering
-
Stellar Biotechnologies Announces Pricing of $6.75 Million Registered Direct Offering
-
Capnia Announces Private Placement of Up to $13.8 Million of Convertible Preferred Stock
-
Onconova Announces Price Range and Change of Key Dates for Rights Offering
-
Maxim Group Downgrades Suffolk Bancorp (SCNB) to Hold
-
Regenerx Biopharma (RGRX) Announces 5.15M Share Private Stock Placement
-
RegeneRx Announces $1.75 Million Private Placement
-
Notable Analyst Rating Changes 6/23: (POST) (HD) (MU) Upgraded; (SJM) (TSLA) (CACI) Downgraded
-
Maxim Group Starts eBay (EBAY) at Buy
-
Maxim Group Starts Groupon, Inc. (GRPN) at Buy
-
Maxim Group Starts Amazon.com (AMZN) at Buy
-
Streetinsider.com's Hot Lunchtime Reads 6/20: (GPRO) (SQ) (INO) (MSFT)
-
Maxim Group Reiterates Bullish View on Inovio (INO) as Zika Vaccine Gets Green Light For Human Study
-
Onconova Informs Stockholders of Key Dates Related to Announced Rights Offering
-
Viveve(R) Announces Closing of $15.5 Million Underwritten Public Offering
-
Oculus Innovative Sciences (OCLS): Building a Commercial Presence - Maxim Group


